Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5)

Clinical trial NCT00523211 · COMPLETED

Trial details

NCT number: NCT00523211
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

HIV Infections Acquired Immunodeficiency Syndrome

Start date: 2007-07-01
Primary completion: 2009-06-01
Enrollment: 506

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.